Clinical Trial Update: Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

View source ↗

Summary

The document notes that a National Cancer Institute–sponsored clinical trial evaluating breast stem cells in women at average risk and at increased risk for bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Status: COMPLETED